 MORRISVILLE, N.C., Nov. 18, 2020 GLOBE NEWSWIRE -- Syneos Health, Inc. Nasdaq: SYNH the Company or Syneos Health, the only fully integrated biopharmaceutical solutions organization combining a CRO Contract Research Organization and a CCO Contract Commercial Organization, today announced it commenced an offering of 500.0 million aggregate principal amount of senior notes the Notes in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended the Securities Act. The Notes will be guaranteed, jointly and severally, on a senior unsecured basis, by certain of the Companys subsidiaries. 